Llwytho...
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
Background: Given the significant activity and tolerability of gemcitabine in patients with relapsed Hodgkin's lymphoma (HL), the critical role that nuclear factor kappa B (NF-κB) appears to play in the pathogenesis of this tumor, the ability of bortezomib to inhibit NF-κB activity, and laborat...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2008
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2735068/ https://ncbi.nlm.nih.gov/pubmed/18504251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn365 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|